Reports for APOTEX INC

Company Name

APOTEX INC

Totals

Shortage reports

3356

Actual shortage: 218 (6%)
Anticipated shortage: 0 (0%)
Avoided shortage: 10 (0%)
Resolved: 3128 (93%)

Discontinuation Reports

359

To be discontinued: 24 (7%)
Discontinued: 335 (93%)
Reversed: 0 (0%)

Late reports

144 (4%)

Overdue reports

62 (26%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-OLANZAPINE ODT 10MG TABLET (ORALLY DISINTEGRATING) Resolved 2017-11-13 2018-08-15 29036
APO-OLANZAPINE ODT 15MG TABLET (ORALLY DISINTEGRATING) Resolved 2017-11-15 2018-01-31 29348
APO-OLANZAPINE ODT 20MG TABLET (ORALLY DISINTEGRATING) Resolved 2023-12-15 2024-01-05 213553
APO-OLANZAPINE ODT 15MG TABLET (ORALLY DISINTEGRATING) Resolved 2023-12-15 2024-01-05 213576
APO-OLANZAPINE ODT 10MG TABLET (ORALLY DISINTEGRATING) Resolved 2023-12-22 2024-01-05 214223
APO-OLANZAPINE ODT 20MG TABLET (ORALLY DISINTEGRATING) Resolved 2024-04-12 2024-05-24 225008
APO-OLANZAPINE ODT 15MG TABLET (ORALLY DISINTEGRATING) Resolved 2019-12-05 2020-01-07 100310
APO-OLANZAPINE ODT 10MG TABLET (ORALLY DISINTEGRATING) Resolved 2020-04-13 2020-12-21 111928
APO-OLANZAPINE ODT 5MG TABLET (ORALLY DISINTEGRATING) Resolved 2020-04-13 2020-12-21 111931
APO-OLANZAPINE ODT 15MG TABLET (ORALLY DISINTEGRATING) Resolved 2020-05-08 2020-12-28 114309
APO-OLANZAPINE ODT 20MG TABLET (ORALLY DISINTEGRATING) Resolved 2020-05-08 2020-12-28 114312
APO-OLANZAPINE ODT 15MG TABLET (ORALLY DISINTEGRATING) Resolved 2019-09-04 2019-10-01 92984
APO-OLANZAPINE ODT 20MG TABLET (ORALLY DISINTEGRATING) Resolved 2022-05-20 2022-07-22 161032
APO-OLANZAPINE ODT 5MG TABLET (ORALLY DISINTEGRATING) Resolved 2022-06-17 2022-07-28 162904
APO-OLANZAPINE ODT 20MG TABLET (ORALLY DISINTEGRATING) Resolved 2024-07-18 2024-09-20 233349
APO-OLANZAPINE ODT 5MG TABLET (ORALLY DISINTEGRATING) Resolved 2025-01-16 2025-02-14 247901
APO-OLANZAPINE ODT 5MG TABLET (ORALLY DISINTEGRATING) Resolved 2025-04-10 2025-04-25 254847
APO-OLANZAPINE ODT 20MG TABLET (ORALLY DISINTEGRATING) Resolved 2017-06-13 2017-07-31 12689
APO-OLANZAPINE ODT 15MG TABLET (ORALLY DISINTEGRATING) Resolved 2017-08-08 2017-08-23 18546
APO-OLANZAPINE ODT 20MG TABLET (ORALLY DISINTEGRATING) Resolved 2021-10-29 2021-11-26 148503

Showing 2121 to 2140 of 3356

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-DILTIAZ TZ 360MG CAPSULE (EXTENDED RELEASE) Discontinued 2017-03-13 2017-03-13 1078
APO-DIPYRIDAMOLE 25MG TABLET Discontinued 2019-12-20 2020-07-30 101888
APO-DIPYRIDAMOLE 50MG TABLET Discontinued 2019-12-20 2020-07-30 101891
APO-DIPYRIDAMOLE 75MG TABLET Discontinued 2019-12-20 2019-12-21 101880
APO-DIVALPROEX 250MG TABLET (ENTERIC-COATED) Discontinued 2018-09-07 2018-09-15 60438
APO-DOCUSATE SODIUM 100MG CAPSULE Discontinued 2018-02-23 2019-03-29 40733
APO-DONEPEZIL 10MG TABLET Discontinued 2018-09-07 2018-09-15 60443
APO-DONEPEZIL 10MG TABLET Discontinued 2018-09-07 2018-09-15 60447
APO-DONEPEZIL 5MG TABLET Discontinued 2018-09-07 2018-10-12 60450
APO-DONEPEZIL 5MG TABLET Discontinued 2018-09-07 2019-02-13 60453
APO-DOXY CAP 100MG 100MG CAPSULE Discontinued 2018-09-07 2018-09-29 60459
APO-DOXY TABS 100MG 100MG TABLET Discontinued 2017-03-30 2018-02-05 4707
APO-ENALAPRIL 10MG TABLET Discontinued 2018-09-07 2018-12-05 60462
APO-ENALAPRIL 20MG TABLET Discontinued 2018-09-07 2018-11-19 60465
APO-ENALAPRIL 5MG TABLET Discontinued 2018-09-07 2018-11-02 60468
APO-ESCITALOPRAM 20MG TABLET Discontinued 2018-09-07 2018-09-15 60471
APO-ESCITALOPRAM 10MG TABLET Discontinued 2018-09-07 2018-11-16 60474
APO-EXEMESTANE Discontinued 2019-06-12 2019-06-12 86552
APO-FAMOTIDINE TAB 20MG USP Discontinued 2018-09-07 2018-09-15 60477
APO-FAMOTIDINE TAB 40MG USP Discontinued 2018-09-07 2018-09-15 60480

Showing 141 to 160 of 359